Rubius Therapeutics Inc. sell marge
Start price
14.12.20
/
50%
€7.30
Target price
14.12.21
-
Performance (%)
169.86%
End price
07.07.21
€19.70
Summary
This prediction ended on 07.07.21 with a price of €19.70. The price for Rubius Therapeutics Inc. massively increased, which is bad news for the SELL prediction by marge. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Rubius Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 2.594% | -1.861% | 13.242% | 16.867% |
| iShares Nasdaq 100 | 3.553% | -2.064% | 38.293% | 45.898% |
| iShares Nikkei 225® | 0.687% | -8.704% | 17.510% | 2.760% |
| iShares S&P 500 | 2.209% | -1.988% | 27.632% | 42.955% |
According to marge what are the pros and cons of Rubius Therapeutics Inc. for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Comments by marge for this prediction
In the thread Rubius Therapeutics Inc. diskutieren
Sell Rubius Therapeutics Inc.